These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18472240)

  • 21. Assessment of three different software systems in the evaluation of dynamic MRI of the breast.
    Kurz KD; Steinhaus D; Klar V; Cohnen M; Wittsack HJ; Saleh A; Mödder U; Blondin D
    Eur J Radiol; 2009 Feb; 69(2):300-7. PubMed ID: 18060715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood oxygen level-dependent MRI for the monitoring of neoadjuvant chemotherapy in breast carcinoma: initial experience.
    Fan B; Wang XY; Yang XD; Zhong H; Wu CX; Jiang XX
    Magn Reson Imaging; 2011 Feb; 29(2):153-9. PubMed ID: 21129879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
    Loo CE; Straver ME; Rodenhuis S; Muller SH; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
    J Clin Oncol; 2011 Feb; 29(6):660-6. PubMed ID: 21220595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotropic proton-density-weighted high-resolution MRI for volume measurement of reconstructed orbital fractures--a comparison with multislice CT.
    Kolk A; Pautke C; Wiener E; Schott V; Wolff KD; Horch HH; Rummeny EJ
    Magn Reson Imaging; 2008 Oct; 26(8):1167-74. PubMed ID: 18524524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relaxo-volumetric multispectral quantitative magnetic resonance imaging of the brain over the human lifespan: global and regional aging patterns.
    Saito N; Sakai O; Ozonoff A; Jara H
    Magn Reson Imaging; 2009 Sep; 27(7):895-906. PubMed ID: 19520539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
    Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
    Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
    Kang DK; Kim TH; Han TS; Kim KS; Yim H
    J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution of MRI for monitoring response to neoadjuvant chemotherapy in the management of breast cancer].
    Fellah L; Berlière M; Galant C; Akle N; Leconte I
    JBR-BTR; 2009; 92(4):224-6. PubMed ID: 19803103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
    Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
    Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
    Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
    J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of magnetic resonance imaging in the pre and postchemotherapy evaluation in locally advanced breast carcinoma.
    Belli P; Romani M; Costantini M; Magistrelli A; Terribile D; Nardone L; Pastore G
    Rays; 2002; 27(4):279-90. PubMed ID: 12696290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic breast MRI in the course of neoadjuvant chemotherapy: standardized evaluation of tumor size and enhancement parameters in correlation to different histopathologic characteristics.
    Schlossbauer T; Sourbron S; Scholz A; Mosner M; Kahlert S; Böhm H; Reiser M; Hellerhoff K
    Acad Radiol; 2010 Apr; 17(4):441-9. PubMed ID: 20207315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
    An YY; Kim SH; Kang BJ; Lee AW
    J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
    Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
    Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Objective quantification of intervertebral disc volume properties using MRI in idiopathic scoliosis surgery.
    Violas P; Estivalezes E; Briot J; Sales de Gauzy J; Swider P
    Magn Reson Imaging; 2007 Apr; 25(3):386-91. PubMed ID: 17371729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial.
    van Egdom LSE; Lagendijk M; Heijkoop EHM; Koning AHJ; van Deurzen CHM; Jager A; van Lankeren W; Koppert LB
    Eur J Radiol; 2018 Jul; 104():94-100. PubMed ID: 29857873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).
    Danishad KK; Sharma U; Sah RG; Seenu V; Parshad R; Jagannathan NR
    NMR Biomed; 2010 Apr; 23(3):233-41. PubMed ID: 20175134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy.
    Takeda K; Kanao S; Okada T; Ueno T; Toi M; Ishiguro H; Mikami Y; Tanaka S; Togashi K
    Eur J Radiol; 2012 Sep; 81(9):2148-53. PubMed ID: 21664779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.